Diabetes and the risk of developing Parkinson's disease in Denmark.
about
Diabetes and risk of Parkinson's disease: a systematic review and meta-analysisConverging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's diseaseDiabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studiesAntihypertensive agents and risk of Parkinson's disease: a nationwide cohort studyIn utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder.Insulin resistance and gray matter volume in neurodegenerative disease.Parkinson's disease is related to an increased risk of ischemic stroke-a population-based propensity score-matched follow-up study.Insulin resistance impairs nigrostriatal dopamine functionAnalysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neuronsAstroglial pentose phosphate pathway rates in response to high-glucose environments.Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseasesRisk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications.Role of vitamin d in Parkinson's disease.Increased Risk of Dementia in Patients With Chronic Obstructive Pulmonary Disease.Cardiovascular physiology in premotor Parkinson's disease: a neuroepidemiologic studyGout and the risk of Parkinson's disease in Denmark.Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies.Etiologic Framework for the Study of Neurodegenerative Disorders as Well as Vascular and Metabolic Comorbidities on the Grounds of Shared Epidemiologic and Biologic FeaturesActivation of ATP-sensitive potassium channels enhances DMT1-mediated iron uptake in SK-N-SH cells in vitro.Increased risk of Parkinson disease with diabetes mellitus in a population-based study.The emerging role of nutrition in Parkinson's disease.Targeting metabolic inflammation in Parkinson's disease: implications for prospective therapeutic strategies.Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders.Statin therapy prevents the onset of Parkinson disease in patients with diabetes.Restless legs syndrome in end-stage renal disease: a multicenter study in Taiwan.The association between chronic obstructive pulmonary disease and Parkinson's disease: a nationwide population-based retrospective cohort study.Is cardiac function impaired in premotor Parkinson's disease? A retrospective cohort study.Biological and Clinical Implications of Comorbidities in Parkinson's Disease.Aβ exacerbates α-synuclein-induced neurotoxicity through impaired insulin signaling in α-synuclein-overexpressed human SK-N-MC neuronal cells.Exploring the Association between Statin Use and the Risk of Parkinson's Disease: A Meta-Analysis of Observational Studies.Mitochondrial Chaperones in the Brain: Safeguarding Brain Health and Metabolism?The Therapeutic Potential of Metformin in Neurodegenerative DiseasesElucidating the multi-targeted anti-amyloid activity and enhanced islet amyloid polypeptide binding of -wrapinsPioglitazone use and Parkinson's disease: a retrospective cohort study in Taiwan
P2860
Q26849796-A06BFF61-A7A7-45BE-82D9-46F91DFB838BQ28074143-0F000160-A805-4886-BC02-1B21D0BF9138Q28538916-4D811236-CF0A-402B-BF31-9BFA5E742DDDQ33727268-13A4F1F9-9706-47E6-A8B8-1C7AEF3B0FC2Q34040844-FFC75B46-F590-4A69-AD13-3A3F066EB7C4Q34412464-0150BB26-E2B7-4E1C-A496-2D861A820249Q34983826-56B755FB-88F5-4F26-8FC1-CB96D0D5FA26Q35202338-658D8AFB-7315-425E-98C6-197C7A9047CDQ35728813-6258DFD3-93FE-4B42-A316-3B8BE80ED8A3Q35846489-E951E75F-17DB-43BF-816C-F51B6C060893Q35858073-DFF309CF-314B-49E3-AB94-51C32624B754Q35898211-A34BF8A7-D337-4319-9212-F248A92829E0Q35949729-8C041EBE-EF51-486F-AB7C-AB9F5D6FBD0FQ36194290-1D0F29E8-3C78-489B-BE9F-1C398B9664D5Q36838860-20E343E6-492B-4297-831E-3F2849EEC21CQ36847424-51573BA4-7CBE-43F8-9A39-A32AFF9978CEQ36891855-54C0DE0B-CB5B-4427-8A07-0987B6409F43Q36995708-5BB984B8-3AE3-4EAD-BA76-BF0B82790722Q37267127-609FBFB7-9B0B-4E57-861C-949A7E783456Q37613409-FAC2A6B7-A631-473F-BCFB-E56B53AF1C98Q37622710-6988A28B-544E-4302-8612-78A03F2F907FQ37962621-F698D10C-2DF1-4C09-ADF6-47CF2847439EQ38075505-3D559142-BEF3-4161-9230-C5E07AF82E8EQ39546196-11B90AB0-4F04-46DE-AE5B-64A25D8C28A3Q43620593-12D5FE44-8F70-44D6-8484-0A6974F99C93Q43693957-548D6F42-FFF9-4E62-A911-FE902F25F43FQ44177958-9D946A83-4CF0-45B3-AB81-7A454DAD30DDQ47137783-F51E949D-68AA-4C8C-95DD-446E13FC5D5CQ47577647-34FCA4FD-C884-4B0A-8732-9B994682BF97Q47585241-33F59946-C8DA-406E-8844-BFBD5680280EQ55283805-5429407D-04C6-4A58-965F-A2C9330CA281Q57175337-09674077-CBD4-48EC-AEA0-540BAEFC93E6Q58566190-F39AD078-6061-4B04-9F05-9D634932B333Q58694525-B59B8BB5-13EB-4AE9-9152-08BCF80E09DE
P2860
Diabetes and the risk of developing Parkinson's disease in Denmark.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Diabetes and the risk of developing Parkinson's disease in Denmark.
@en
type
label
Diabetes and the risk of developing Parkinson's disease in Denmark.
@en
prefLabel
Diabetes and the risk of developing Parkinson's disease in Denmark.
@en
P2093
P2860
P356
P1433
P1476
Diabetes and the risk of developing Parkinson's disease in Denmark
@en
P2093
Beate Ritz
Johnni Hansen
Lene Wermuth
P2860
P304
P356
10.2337/DC10-1333
P407
P577
2011-03-16T00:00:00Z